World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 July 2021
Main ID:  NCT04948450
Date of registration: 04/06/2021
Prospective Registration: Yes
Primary sponsor: National Geriatric Hospital
Public title: Multidomain Intervention Programs for Older People With Dementia With Dementia
Scientific title: Multidomain Intervention Programs for Older People With Dementia
Date of first enrolment: August 1, 2021
Target sample size: 152
Recruitment status: Not yet recruiting
URL:  https://clinicaltrials.gov/show/NCT04948450
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Vietnam
Contacts
Name:     Thanh X Nguyen, Master
Address: 
Telephone: +84983277646
Email: xuanthanh1901vlk@gmail.com
Affiliation: 
Name:     Nguyen X Thanh, Master
Address: 
Telephone: +84983277646
Email: xuanthanh1901vlk@gmail.com
Affiliation: 
Name:     Anh T Nguyen, PhD
Address: 
Telephone:
Email:
Affiliation:  National Geriatric Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- aged 60-79 years old

- living in the community

- who have a diagnosis of mild-moderate vascular dementia or mixed dementia according to
DSM 5 criteria.

- receiving pharmacological treatment for dementia (cholinesterase inhibitors,
memantine), must be on a stable dose for at least 3 months prior to the study.

- must be able to mobilise independently with or without a mobility aid and without
physical assistance.

- must have a caregiver who either lives with the participant or visits for at least
four hours per week.

Exclusion Criteria:

- acute and malignant diseases (advanced cancers, end-stage chronic diseases, acute
myocardial infarction, stroke)

- Symptomatic cardiovascular disease, coronary revascularization within 1 year

- Clinical evidence of schizophrenia, severe depression, psychiatric or bipolar disorder
(according to DSM-IV TR criteria) [12]

- Alcoholism or substance dependence (according to DSM-5 criteria) [13], currently, or
within the past 2 years

- Severe loss of vision, hearing or communicative ability (according to the interRAI
Community Health Assessment) [14]

- Participant or family unwilling to participate in the study



Age minimum: 60 Years
Age maximum: 79 Years
Gender: All
Health Condition(s) or Problem(s) studied
Dementia, Mixed
Dementia, Vascular
Intervention(s)
Behavioral: Cognitive stimulation intervention
Behavioral: Physical activity intervention
Other: Reduce of metabolic and vascular risk factors
Primary Outcome(s)
Cognitive performance [Time Frame: Change from Baseline Cognitive performance at 12 months]
Secondary Outcome(s)
Attention function [Time Frame: Change from Baseline Attention function at 12 months]
Behaviours (agitation, aggression) [Time Frame: Change from Baseline Behaviours at 12 months]
Caregiver burden [Time Frame: Change from Baseline Caregiver burden at 12 months]
Caregiver depression [Time Frame: Change from Baseline Caregiver depression at 12 months]
Caregiver quality of life [Time Frame: Change from Baseline Caregiver quality of life at 12 months]
Completers [Time Frame: 12 months]
Dementia severity [Time Frame: Change from Baseline Dementia severity at 12 months]
Excutive function using Clock drawing test [Time Frame: Change from Baseline Clock drawing test at 12 months]
Excutive function using Trails B test [Time Frame: Change from Baseline Trails B test at 12 months]
Fall risks [Time Frame: Change from Baseline Fall risks at 12 months]
Functional ability [Time Frame: Change from Baseline Functional ability at 12 months]
Memory function [Time Frame: Change from Baseline Memory function at 12 months]
Prevalence of fall [Time Frame: Change from Baseline Prevalence of fall at 12 months]
Quality of sleep [Time Frame: Change from Baseline Quality of sleep at 12 months]
Secondary ID(s)
AG064688
CB1.02
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history